Palonosetron, Aprepitant, and Low-Dose Dexamethasone in Preventing Nausea and Vomiting in Patients Undergoing High-Dose Chemotherapy and Stem Cell Transplant for Multiple Myeloma or Lymphoma
This study is currently recruiting participants.
Study NCT00631930
Information provided by National Cancer Institute (NCI)
First Received: March 7, 2008
Last Updated: June 16, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: